Center for Regenerative Medicine

What Center for Regenerative Medicine does

The Center for Regenerative Medicine (CReM) is a stem cell and regenerative medicine research unit housed within Boston University, founded in 2008 and based in Boston, Massachusetts. Its publicly stated mission includes building a new lung regeneration facility, indicating a programmatic focus on pulmonary regenerative medicine alongside broader stem cell research. The Center operates with a small team of 1-10 employees and is led by Director Darrell Kotton together with Co-Directors Gustavo Mostoslavsky and George Murphy. Its web presence is anchored at bu.edu/dbin/stemcells/, consistent with its role as an academic research center rather than a commercial enterprise.

The Center's underlying technology is centered on stem cell research infrastructure housed at Boston University, an Association of American Universities member institution that reported $574.25M in total research awards in FY25 across the broader university. No proprietary products, platforms, APIs, or commercial service offerings are documented in the available source material; the entity does not maintain mobile applications, public APIs, or disclosed pricing. Its website (bu.edu/dbin/stemcells/) suggests a database- and stem-cell-line orientation typical of an academic regenerative medicine core.

From a business model standpoint, the Center functions as a research unit within Boston University, a nonprofit institution whose controlling entity is the Trustees of Boston University per BU's Digital Privacy Statement. Only one funding event is disclosed — a $1.74M round dated 2017-06-16 — and no investors, lead backers, revenue figures, customer segments, or GTM motion are documented. No management team, partnerships, awards, patents, regulatory actions, M&A activity, or product launches are recorded in the aggregated data, leaving the Center's commercial economics, customer base, and competitive positioning largely undefined.

Name

Center for Regenerative Medicine

Legal name

Center for Regenerative Medicine (legal name not explicitly stated in the provided source data; the entity appears to be referenced only by its common name)

Website

https://bu.edu

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

The Center for Regenerative Medicine (CReM) is a stem cell and regenerative medicine research unit within Boston University, founded in 2008 and based in Boston. Led by Director Darrell Kotton and Co-Directors Gustavo Mostoslavsky and George Murphy, it is building a new lung regeneration facility and operates with a small team of 1-10 employees.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Research

akta.pro primary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

• Stem cell research
• Regenerative medicine
• Lung regeneration
• Biomedical research
• Tissue engineering

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

The Center for Regenerative Medicine (CReM) is a research center at Boston University that conducts stem cell and regenerative medicine research, with a stated goal of building a new lung regeneration facility. It operates as an academic research unit developing regenerative medicine approaches and tissue engineering capabilities. The Center was established in 2008 and operates with 1-10 employees under a Director and two Co-Directors.

Product overview

The provided source material does not describe a distinct Center for Regenerative Medicine product, platform, or service offering. The aggregated pages describe Boston University's general academic, research, admissions, technology services, and policy content, with no specific products, modules, or named offerings attributable to a Center for Regenerative Medicine.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Direct peers

• McGowan Institute for Regenerative Medicine: University of Pittsburgh's flagship regenerative medicine research center, conducting organ repair and cell therapy research. Directly comparable as an academic institute pursuing tissue/organ regeneration, including pulmonary applications.
• Wake Forest Institute for Regenerative Medicine: Pioneering academic regenerative medicine institute at Wake Forest, focused on engineering human tissues and organs. Comparable as a university-based center translating stem-cell and regenerative science toward organ repair, including lung.
• Stanford Institute for Stem Cell Biology and Regenerative Medicine: Stanford's interdisciplinary institute for stem-cell and regenerative medicine research. Comparable as a major university research center working on lung and other organ regeneration with a translational mandate.
• Harvard Stem Cell Institute: Cross-campus Harvard initiative in stem-cell and regenerative biology, including lung regeneration programs. Comparable as an elite academic research consortium with multi-disease organ repair focus.
• Cedars-Sinai Regenerative Medicine Institute: Cedars-Sinai's institute focused on cell therapy and regenerative medicine, including lung applications. Comparable as a US academic medical center institute pursuing translational regenerative medicine.

Emerging players

• Columbia Center for Translational Immunology: Academic center working on cell-based and immune engineering therapies with translational pipeline. Partially comparable as a university-based translational cell-therapy program in an adjacent tissue-repair niche.
• Gladstone Institutes: Independent biomedical research institute affiliated with UCSF focused on regenerative biology and disease. Comparable as a research-focused entity working on stem-cell biology and organ regeneration.

Broad incumbents

• California Institute for Regenerative Medicine (CIRM): State agency funding stem-cell and regenerative medicine research across California institutions. Comparable as a major funder and ecosystem builder in regenerative medicine that supports academic centers like CReM through grants and infrastructure.
• New York Stem Cell Foundation: Independent nonprofit advancing stem-cell research and translational programs. Comparable as a non-academic organization accelerating regenerative medicine research with grant-making and lab capabilities.

Others

• International Society for Stem Cell Research (ISSCR): Professional society setting standards and convening the global stem-cell research community. Comparable as an ecosystem organization relevant to any academic regenerative medicine center, though not a research peer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/CReM_Boston
• LinkedInlinkedin.com/company/boston-university

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Center for Regenerative Medicine